Skip to main content
$2.81 -$0.05 (-1.7%)

01:31 PM EST on 01/28/22

Accelerate Diagnostics, Inc. (NASDAQ:AXDX)

CAPS Rating: 1 out of 5

Current Price $2.81 Mkt Cap $199.2M
Open $2.86 P/E Ratio 0.00
Prev. Close $2.86 Div. (Yield) $0.00 (0.0%)
Daily Range $2.75 - $2.88 Volume 203,982
52-Wk Range $2.75 - $15.00 Avg. Daily Vol. 404,051


How do you think NASDAQ:AXDX will perform against the market?

Add Stock to CAPS Watchlist

All Players

23 Outperform
28 Underperform

All-Star Players

6 Outperform
16 Underperform

Wall Street

0 Outperform
0 Underperform

Top NASDAQ:AXDX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

TMFkodyk123 (54.72)
Submitted July 28, 2021

Accelerate's recent PhenoTest BC Kit study results should lead to increased market acceptance of the company's products in a rapidly growing bloodstream infection testing market.

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!



Fools bullish on NASDAQ:AXDX are also bullish on:

Fools bearish on NASDAQ:AXDX are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about AXDX.


Member Avatar TMFSecurity (92.46) Submitted: 11/16/2021 9:54:39 AM : Underperform Start Price: $6.60 NASDAQ:AXDX Score: +50.08



Member Avatar TMFkodyk123 (54.72) Submitted: 7/28/2021 4:36:18 PM : Outperform Start Price: $6.84 NASDAQ:AXDX Score: -57.64

Accelerate's recent PhenoTest BC Kit study results should lead to increased market acceptance of the company's products in a rapidly growing bloodstream infection testing market.


Member Avatar TMFSaintCroix (99.09) Submitted: 3/24/2020 11:48:45 AM : Outperform Start Price: $6.45 NASDAQ:AXDX Score: -138.29

Fascinating medical device company. Accelerate sells a device to hospitals that tests for bacteria and fungus infections. The status quo is to run a test on a patient, send it off to a lab, and get the response back in 2-3 days. With this machine the doctors can get a response back in a matter of hours. And that makes a big difference in treatment.

Sepsis is the body's response to a bacterial or fungus infection. 270,000 people die from sepsis every year in the U.S. Also sepsis costs hospitals an estimated $27 billion dollars each year. It's the #1 cause of hospitalizations in the U.S. Most of these sepsis deaths are preventable if the doctors know what the infection is.

Globally sepsis kills 8 million people every year, including 3 million children.

Status quo is to run the test, send it off to the lab, get it back several days later. Often too late to help the patient. Accelerate Diagnostics wants to speed up this process. Cut the wait time by 75%. 40+ hours faster.

Company has the only cleared FDA solution for doing this test at the hospital.

Reminds me of Intuitive Surgical because the company has a razor-and-blades business model. You sell the device, a one time purchase, but most of your money is recurring revenue from the use of the device. Thus it's very important to have a large installed base of customers. Once they have the machine, hospital is locked in. They don't say this but it's probably a good idea to sell the machine at cost, or even below cost, so you have the hospitals in your network.

Right now they are at the stage of their business where they go from selling to the top hospitals (influencers) to selling to all hospitals. This year they are projecting 300-400 instruments sold. Consumables (the recurring revenues from the use of the device) is growing by 150%.

They just made a CEO change. Previous CEO was the guy who got this device approved. More of a scientist-type guy I think. Now they're switching to a sales guy. They hired the guy who was the CEO of Roche Diagnostics. Roche is a huge company ($275 billion market cap) so to have the CEO of their diagnostic division step down to become COO of this tiny company is a huge signal to me. He really thinks he can drive this business forward. They hired him as COO in September so he can spend a few months learning the business before he becomes CEO next month. He wants to put this device in every hospital in the U.S. There are 5564 hospitals. Right now they've only got 200 or so so huge runway of growth.

A guy on the board just bought $136,000 worth of shares at $14 a share.


Find the members with the highest scoring picks in AXDX.

Score Leader


HDTVBG (71.46) Score: +228.54

The Score Leader is the player with the highest score across all their picks in AXDX.

Member Name Member
Call Time
Score Commentary
FSaucy 95.91 9/28/2015 Underperform NS $17.23 -83.58% +127.07% +210.65 0 Comment
rmatzen < 20 10/21/2015 Underperform 3Y $15.97 -82.28% +115.19% +197.47 1 Comment
deepcrisis 99.06 8/3/2015 10/22/2020 Underperform 5Y $27.64 -89.76% +106.92% +196.68 0 Comment
valueoftiming 28.12 8/5/2015 Underperform 5Y $23.50 -87.96% +107.45% +195.41 0 Comment
evergreen5555 72.06 6/13/2016 11/19/2021 Underperform NS $14.97 -81.10% +108.00% +189.10 0 Comment
TMFBabo 100.00 5/23/2016 Underperform 5Y $11.85 -76.12% +112.03% +188.15 0 Comment
TinyCapsWatch 99.85 7/18/2016 Underperform 5Y $19.65 -85.60% +101.64% +187.23 0 Comment
benedict23 83.86 6/8/2016 Underperform 5Y $14.02 -79.81% +105.57% +185.38 0 Comment
downwithpumpers 97.40 7/31/2017 Underperform 5Y $26.32 -89.25% +76.27% +165.52 0 Comment
King2061x 52.18 8/8/2017 Underperform 5Y $23.05 -87.72% +75.52% +163.25 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for AXDX.